Journal of Immunotherapy and Precision Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 50.8% | 1.370 | Q1 | 90.6% |
| 2024 | 3.2 | Q2 | 60.7% | 1.285 | Q1 | 89.7% |
| 2023 | — | — | 0.668 | Q3 | 74.3% | |
| 2022 | — | — | 0.393 | Q3 | 58.7% | |
| 2021 | — | — | 0.272 | Q4 | 48.4% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2590-017X
ISSN
2666-2345
country
UScoverage
2018-2026